Company Profile

Novo Nordisk A/S

Novo Allé

Bagsvaerd 2880 Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

YEAR FOUNDED:

1922

LEADERSHIP:

Founders: August Krogh and Marie Krogh

CEO: Lars Rebien Sørensen

CFO: Jesper Brandgaard

CSO (Scientific): Mads Krosgsgaard Themsen

JOBS:

Please click here for Novo Nordisk job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW NOVO NORDISK:

Tweets by Novo Nordisk

Key Statistics

Email:
Ownership: Public

Web Site: Novo Nordisk A/S
Employees: 13395
Symbol: NVO

Industry
Big Pharma

Segment
Medical Device - Diabetes/Obesity
Research and Development

Collaborations
CelTor Biosystems, Inc. Research collaboration
Aradigm Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.
Maxygen, Inc.
Intergen Company

Company News

Novo Nordisk A/S (NVO) - Share Repurchase Programme 9/25/2017 11:46:18 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 9/18/2017 8:24:30 AM

Novo Nordisk A/S (NVO) Release: Tresiba Trial Shows That People With Type 2 Diabetes Who Avoid Severe Hypoglycemia Have A Reduced Risk Of Death 9/15/2017 9:49:45 AM

Novo Nordisk A/S (NVO) Release: Xultophy Reduces Cardiovascular Risk Factors In People With Type 2 Diabetes 9/13/2017 10:21:33 AM

Novo Nordisk A/S (NVO) Release: Fiasp Significantly Improved Overall Blood Sugar Control In Type 1 Diabetes Long-Term 9/12/2017 11:08:55 AM

Novo Nordisk A/S (NVO) Release: More People Treated With Once-Weekly Semaglutide Achieved Reductions In Both Glucose And Weight Vs. Comparator Treatments 9/12/2017 10:53:02 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 9/11/2017 11:23:51 AM

Novo Nordisk A/S (NVO) To Pay $58.7 Million For Failing To Warn Doctors Of Cancer Risk For Diabetes Drugs 9/6/2017 6:54:06 AM

Novo Nordisk A/S (NVO): Share Repurchase Programme 9/5/2017 11:09:28 AM

Novo Nordisk A/S (NVO) - Share Repurchase Programme 8/28/2017 10:20:42 AM

...

//-->